Table 1 Comparison of marker mean fluorescent intensity on Do4787, Do3528, and Do9432 macrophages

Sample

Mock

HIV-GFP+

Bystander

Mock

HIV-GFP+

Bystander

Mock

HIV-GFP+

Bystander

Mock

HIV-GFP+

Bystander

Day 0 Avg

39.12 (n = 8)

n/a

n/a

48.21

n/a

n/a

68.57

n/a

n/a

68.66

n/a

n/a

Day 0 SD

32.61

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

Significance p < .05

n/a

Day 7 Avg

59.81 (n = 9)

39.15

32.28

54.49

44.38

29.24

53.85 (n = 4)

30.59

43.45

47.69

20.95

16.22

Day 7 SD

42.48

19.45

9.19

n/a

n/a

11.01

68.1

24.03

18.78

3.555

n/a

n/a

Significance p < .05

n/a

n/a

n/a

Day 14 Avg

52.98 (n = 18)

49.2

37.42

56.03 (n = 3)

49.41

33.29

86.91 (n = 3)

49.99

34.05

71.86

67.91

53.59

Day 14 SD

24.77

20.93

8.28

21.36

22.33

15.44

61.77

17.57

8.67

2.44

22.27

8.62

Significance p < .05

*

Day 21–28 Avg

74.56 (n = 17)

66.23

52.9

63.53 (n = 6)

59.91

72.67

114.32 (n = 9)

74.33

33.49

97.86

128.51

96.52

Day 21–28 SD

28.54

24.59

15.98

32.27

32.81

44.41

71.02

26.29

25.85

54.05

43.18

79.6

Significance p < .05

*

Day 29–35 Avg

66.64 (n = 10)

50.81

35.91

50.76 (n = 3)

46.81

41.67

112.29 (n = 4)

86.41

60.91

62.45

100.37

66.34

Day 29–35 SD

23.99

24.43

12.39

19.88

16.75

12.28

57.61

34.87

7.52

36.22

82.29

12.36

Significance p < .05